{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:07:02Z","timestamp":1770980822985,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1002\/jps.23154","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T14:03:47Z","timestamp":1336572227000},"page":"2668-2674","source":"Crossref","is-referenced-by-count":13,"title":["Drug Delivery Trends in Clinical Trials and Translational Medicine: Growth in Biologic Molecule Development and Impact on Rheumatoid Arthritis, Crohn's Disease, and Colitis"],"prefix":"10.1016","volume":"101","author":[{"given":"Rodney J.Y.","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny Y.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1002\/jps.23154_bb0010","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/jps.21426","article-title":"Drug delivery trends in clinical trials and translational medicine","volume":"97","author":"Chien","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23154_bb0015","unstructured":"NIH. Accessed March 13, 2012, at: http:\/\/clinicaltrials.gov\/."},{"issue":"6","key":"10.1002\/jps.23154_bb0020","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jps.21649","article-title":"Drug delivery trends in clinical trials and translational medicine: Updated analysis of ClinicalTrials.gov database","volume":"98","author":"Ho","year":"2009","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.23154_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jps.22253","article-title":"Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations","volume":"100","author":"Chien","year":"2011","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1002\/jps.23154_bb0030","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1002\/jps.22205","article-title":"Prodrugs: Some thoughts and current issues","volume":"99","author":"Stella","year":"2010","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.23154_bb0035","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1002\/jps.22637","article-title":"Lead PK commentary: Predicting human pharmacokinetics","volume":"100","author":"Rowland","year":"2011","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.23154_bb0040","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/jps.22552","article-title":"PhRMA CPCDC initiative on predictive models of human pharmacokinetics, Part 3: Comparative assessment of prediction methods of human clearance","volume":"100","author":"Ring","year":"2011","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.23154_bb0045","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/jps.22550","article-title":"PHRMA CPCDC initiative on predictive models of human pharmacokinetics, Part 5: Prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach","volume":"100","author":"Poulin","year":"2011","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.23154_bb0050","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1002\/jps.22553","article-title":"PhRMA CPCDC initiative on predictive models of human pharmacokinetics, Part 2: Comparative assessment of prediction methods of human volume of distribution","volume":"100","author":"Jones","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23154_bb0055","series-title":"New Survey Finds Strong Public Interest in Prescription Drug Safety Issues: Americans Trust FDA, But Express Conflicting Views About How to Manage Safety Risks","author":"Csellar","year":"2007"},{"key":"10.1002\/jps.23154_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.59.090506.155819","article-title":"The FDA critical path initiative and its influence on new drug development","volume":"59","author":"Woodcock","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1002\/jps.23154_bb0065","series-title":"Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs","first-page":"2","article-title":"Not all protein drugs and vaccines of the same name are identical","author":"Ho","year":"2003"},{"key":"10.1002\/jps.23154_bb0070","series-title":"Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs","first-page":"371","article-title":"Molecular approaches","author":"Ho","year":"2003"},{"issue":"1","key":"10.1002\/jps.23154_bb0075","doi-asserted-by":"crossref","first-page":"e30275","DOI":"10.1371\/journal.pone.0030275","article-title":"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis","volume":"7","author":"Aaltonen","year":"2012","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1002\/jps.23281","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000}}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915314738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915314738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T10:21:17Z","timestamp":1542968477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915314738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022354915314738"],"URL":"https:\/\/doi.org\/10.1002\/jps.23154","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}